Acorah Software Products - Accounts Production 16.1.300 false true 31 October 2023 1 November 2022 false true No description of principal activity 1 November 2023 31 October 2024 31 October 2024 SC677513 Mr Jonathan Dempsey iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC677513 2023-10-31 SC677513 2024-10-31 SC677513 2023-11-01 2024-10-31 SC677513 frs-core:CurrentFinancialInstruments 2024-10-31 SC677513 frs-bus:PrivateLimitedCompanyLtd 2023-11-01 2024-10-31 SC677513 frs-bus:FilletedAccounts 2023-11-01 2024-10-31 SC677513 frs-bus:Micro-entities 2023-11-01 2024-10-31 SC677513 frs-bus:AuditExempt-NoAccountantsReport 2023-11-01 2024-10-31 SC677513 frs-bus:Director1 2023-11-01 2024-10-31 SC677513 2022-10-31 SC677513 2023-10-31 SC677513 2022-11-01 2023-10-31 SC677513 frs-core:CurrentFinancialInstruments 2023-10-31
Registered number: SC677513
Pathway Biopharma Limited
Unaudited Financial Statements
For The Year Ended 31 October 2024
Egia Financial Limited
Balance Sheet
Registered number: SC677513
2024 2023
£ £
Fixed assets 2,843 2,975
Current assets 50,302 56,833
Prepayments and accrued income 110 542
Creditors: Amounts Falling Due Within One Year (14,273 ) (12,284 )
NET CURRENT ASSETS 36,139 45,091
TOTAL ASSETS LESS CURRENT LIABILITIES 38,982 48,066
Accruals and deferred income (194 ) (155 )
NET ASSETS 38,788 47,911
CAPITAL AND RESERVES 38,788 47,911

Notes

1. General Information
Pathway Biopharma Limited is a private company, limited by shares, incorporated in Scotland, registered number SC677513 . The registered office is 29 Morningside Grove, Edinburgh, EH10 5PX.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 2 (2023: 1)
2 1
For the year ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Jonathan Dempsey
Director
31/03/2025